twist is a potential oncogene that inhibits apoptosis

作者: Roberta Maestro , Angelo P Dei Tos , Yasuo Hamamori , Svetlana Krasnokutsky , Vittorio Sartorelli

DOI: 10.1101/GAD.13.17.2207

关键词: Programmed cell deathTranscription factorGene silencingBiologyRegulation of gene expressionMdm2OncogeneCarcinogenesisCancer researchTwist transcription factor

摘要: Oncogene activation increases susceptibility to apoptosis. Thus, tumorigenesis must depend, in part, on compensating mutations that protect from programmed cell death. A functional screen for cDNAs could counteract the proapoptotic effects of myc oncogene identified two related bHLH family members, Twist and Dermo1. Both these proteins inhibited oncogene- p53-dependent expression bypassed p53-induced growth arrest. These correlated with an ability interfere a reporter impair induction p53 target genes response DNA damage. An underlying explanation this observation may be provided by reduce ARF tumor suppressor. affect indirectly through modulation ARF/MDM2/p53 pathway. Consistent role as potential oncoprotein, promoted colony formation E1A/ras-transformed mouse embryo fibroblasts (MEFs) soft agar. Furthermore, was inappropriately expressed 50% rhabdomyosarcomas, arises skeletal muscle precursors fail differentiate. is known block myogenic differentiation. play multiple roles halting terminal differentiation, inhibiting apoptosis, interfering tumor-suppressor

参考文章(62)
V. S. Ossovskaya, G. I. Deichman, M. A. Nikiforov, S. W. Lowe, A. V. Gudkov, K. Hagen, T. M. F. Connor, p53 modulation of anchorage independent growth and experimental metastasis. Oncogene. ,vol. 13, pp. 1709- 1719 ,(1996)
Gregory J Hannon, Peiqing Sun, Amancio Carnero, Lin Ying Xie, Roberta Maestro, Douglas S Conklin, David Beach, MaRX: An Approach to Genetics in Mammalian Cells Science. ,vol. 283, pp. 1129- 1130 ,(1999) , 10.1126/SCIENCE.283.5405.1129
Wei Gu, Xiao-Lu Shi, Robert G. Roeder, Synergistic activation of transcription by CBP and p53 Nature. ,vol. 387, pp. 819- 823 ,(1997) , 10.1038/42972
Jason D. Weber, Laura J. Taylor, Martine F. Roussel, Charles J. Sherr, Dafna Bar-Sagi, Nucleolar Arf sequesters Mdm2 and activates p53 Nature Cell Biology. ,vol. 1, pp. 20- 26 ,(1999) , 10.1038/8991
Nancy L. Lill, Steven R. Grossman, Doron Ginsberg, James DeCaprio, David M. Livingston, Binding and modulation of p53 by p300/CBP coactivators Nature. ,vol. 387, pp. 823- 827 ,(1997) , 10.1038/42981
Bert Vogelstein, Kenneth W. Kinzler, The Genetic Basis of Human Cancer ,(1997)
Stewart Bates, Andrew C. Phillips, Paula A. Clark, Francesca Stott, Gordon Peters, Robert L. Ludwig, Karen H. Vousden, p14ARF links the tumour suppressors RB and p53. Nature. ,vol. 395, pp. 124- 125 ,(1998) , 10.1038/25867
L. D. Attardi, S. W. Lowe, J. Brugarolas, T. Jacks, Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. The EMBO Journal. ,vol. 15, pp. 3693- 3701 ,(1996) , 10.1002/J.1460-2075.1996.TB00739.X
K. M. Kozopas, T. Yang, H. L. Buchan, P. Zhou, R. W. Craig, MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 3516- 3520 ,(1993) , 10.1073/PNAS.90.8.3516
Sheau-Yann Shieh, Masako Ikeda, Yoichi Taya, Carol Prives, DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 Cell. ,vol. 91, pp. 325- 334 ,(1997) , 10.1016/S0092-8674(00)80416-X